{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:23:14Z","timestamp":1763036594589},"reference-count":29,"publisher":"Springer Science and Business Media LLC","issue":"12","license":[{"start":{"date-parts":[[2011,6,12]],"date-time":"2011-06-12T00:00:00Z","timestamp":1307836800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Nervenarzt"],"published-print":{"date-parts":[[2011,12]]},"DOI":"10.1007\/s00115-011-3324-5","type":"journal-article","created":{"date-parts":[[2011,6,10]],"date-time":"2011-06-10T13:35:22Z","timestamp":1307712922000},"page":"1590-1595","source":"Crossref","is-referenced-by-count":27,"title":["Immunadsorption bei steroidrefrakt\u00e4rem Schub der Multiplen Sklerose"],"prefix":"10.1007","volume":"82","author":[{"given":"E.","family":"Mauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J.","family":"Zwanzger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Hettich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C.","family":"Fassbender","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R.","family":"Klingel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"F.","family":"Heigl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2011,6,12]]},"reference":[{"key":"3324_CR1","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1055\/s-2007-1018024","volume":"20","author":"Bucka","year":"1993","unstructured":"Bucka C, K\u00f6hler W, Hertel G et al (1993) Immunadsorption bei Myasthenia gravis. Wirkungsweise, immunologische Parameter und klinischer Verlauf. Akt Neurol 20:207\u2013213","journal-title":"Akt Neurol"},{"key":"3324_CR2","unstructured":"Diener H, Putzki N (Hrsg) (2008) Leitlinien der Deutschen Gesellschaft f\u00fcr Neurologie. Thieme, Stuttgart; http:\/\/www.dgn.de"},{"key":"3324_CR3","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1056\/NEJMra052130","volume":"354","author":"Frohman","year":"2006","unstructured":"Frohman EM, Racke MK, Raine CS (2006) Multiple sclerosis \u2013 the plaque and its pathogenesis. N Engl Med 354:942\u2013955","journal-title":"N Engl Med"},{"key":"3324_CR4","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1007\/s12028-009-9252-6","volume":"11","author":"Galldiks","year":"2009","unstructured":"Galldiks N, Dohmen C, Neveling M et al (2009) Selective immune adsorption treatment of severe guillain barr\u00e9 syndrome in the intensive care unit. Neurocrit Care 11:317\u2013321","journal-title":"Neurocrit Care"},{"key":"3324_CR5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1212\/WNL.45.2.338","volume":"45","author":"Grob","year":"1995","unstructured":"Grob D, Simpson D, Mitsumoto H et al (1995) Treatment of myasthenia gravis by immunoadsorption of plasma. Neurology 45:338\u2013344","journal-title":"Neurology"},{"key":"3324_CR6","unstructured":"Gold R, Krenzer M, Klinker E et al (2008) Efficacy and safety of immunoadsorption vs plasmapheresis vs combination for treatment of myasthenic crisis: comparative retrospective study on 72\u00a0patients. American Academy of Neurology Chicago, Abstract S57.002 (http:\/\/www.abstracts2view.com\/aan2008chicago\/authorindex.php)"},{"key":"3324_CR7","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1097\/00002480-198907000-00131","volume":"35","author":"Hosokawa","year":"1989","unstructured":"Hosokawa S, Oyamaguchi A, Yoshida O et al (1989) Successful immunoadsorption with membrane plasmapheresis for multiple sclerosis. ASAIO Transactions 35:576\u2013577","journal-title":"ASAIO Transactions"},{"key":"3324_CR8","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/S0140-6736(05)67102-4","volume":"366","author":"Keegan","year":"2005","unstructured":"Keegan M, K\u00f6nig F, McClelland R et al (2005) Relation between humoral pathological changes in multiple sclerosis and response to therapeutic plasma exchange. Lancet 366:579\u2013582","journal-title":"Lancet"},{"key":"3324_CR9","doi-asserted-by":"crossref","unstructured":"Klingel R, Heibges A, Fassbender C (2009) Plasma exchange and immunoadsorption for autoimmune neurologic diseases \u2013 current guidelines and future perspectives. Atheroscler (Suppl 10):129\u2013132","DOI":"10.1016\/S1567-5688(09)71827-6"},{"key":"3324_CR10","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1159\/000025978","volume":"23","author":"K\u00f6hler","year":"2000","unstructured":"K\u00f6hler W, Kalischewski P, Bucka C et al (2000) Immunadsorption versus plasmaexchange: a randomized clinical trial in myasthenia gravis. Kidney Blood Press Res 23:214\u2013347 (P279)","journal-title":"Kidney Blood Press Res"},{"key":"3324_CR11","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.1212\/WNL.33.11.1444","volume":"33","author":"Kurtzke","year":"1983","unstructured":"Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability scale (EDSS). Neurology 33(11):1444\u20131452","journal-title":"Neurology"},{"key":"3324_CR12","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2990.2006.00781.x","volume":"33","author":"Leech","year":"2007","unstructured":"Leech S, Kirk J, Plumb J et al (2007) Persistent endothelial abnormalities and blood-brain barrier leak in primary and secondary progressive multiple sclerosis. Neuropathol Appl Neurobiol 33(1):86\u201398","journal-title":"Neuropathol Appl Neurobiol"},{"key":"3324_CR13","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1002\/1531-8249(200006)47:6<707::AID-ANA3>3.0.CO;2-Q","volume":"47","author":"Lucchinetti","year":"2000","unstructured":"Lucchinetti C, Br\u00fcck W, Parisis J et al (2000) Heterogeneity of mulitiple sclerosis lesions: implications for the pathogenesis of demyelination. Ann Neurol 47(6):691\u2013693","journal-title":"Ann Neurol"},{"key":"3324_CR14","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/j.1365-2362.2005.01518.x","volume":"35","author":"Moldenhauer","year":"2005","unstructured":"Moldenhauer A, Haas J, W\u00e4scher C et al (2005) Immunoadsorption patients with multiple sclerosis: an open-label pilot study. Eur J Clin Invest 35(8):523\u2013530","journal-title":"Eur J Clin Invest"},{"key":"3324_CR15","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1136\/jnnp.2008.146894","volume":"81","author":"Petzold","year":"2010","unstructured":"Petzold A, Pittock S, Lennon V et al (2010) Neuromyelits optica-IgG (aquaporin-4) autoantibodies in immune mediated optic neuritis. J Neurol Neurosurg Psychiatry 81(1):109\u2013111","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"3324_CR16","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1744-9987.2007.00545.x","volume":"12","author":"P","year":"2008","unstructured":"P\u2018ng S, Hughes A, Cooney J (2008) A case report of transfusion-related acute lung injuri during plasma exchange therapy for thrombotic thrombocytopenia purpura. Ther Apher Dial 12(1):78\u201381","journal-title":"Ther Apher Dial"},{"key":"3324_CR17","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1212\/01.WNL.0000138437.99046.6B","volume":"63","author":"Ruprecht","year":"2007","unstructured":"Ruprecht K, Klinker E, Dintelmann T et al (2007) Plasma exchange for severe optic neuritis. Neurology 63:1081\u20131083","journal-title":"Neurology"},{"key":"3324_CR18","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s00115-005-2019-1","volume":"77","author":"Schilling","year":"2006","unstructured":"Schilling S, Linker R, K\u00f6nig F et al (2006) Plasmaaustausch bei steroidresistenten Multiple-Sklerose-Sch\u00fcben \u2013 Klinische Erfahrungen an 16\u00a0Patienten. Nervenarzt 77:430\u2013438","journal-title":"Nervenarzt"},{"key":"3324_CR19","first-page":"38","volume":"14","author":"Schmidt","year":"2010","unstructured":"Schmidt M, Nguyen X, Hourfar M et al (2010) Nebenwirkungen bei der Anwendung von Blutprodukten. H\u00e4motherapie 14:38\u201344","journal-title":"H\u00e4motherapie"},{"key":"3324_CR20","unstructured":"Schmitt E, Appen K von, Behm E, Kundt G et al (1993) Immunoadsorption with phenylalanine-immobilized polyvinyl alcohol versus plasma exchange \u2013 a controlled pilot study in multiple sclerosis. In: Agishi T et al (Hrsg) Therapeutic Plasmapheresis (XII). VSP, Utrecht, p 239\u2013242"},{"key":"3324_CR21","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1046\/j.1525-1594.2002.06920.x","volume":"26","author":"Schneidewind-M\u00fcller","year":"2002","unstructured":"Schneidewind-M\u00fcller JM, Winkler R, Tiess M et al (2002) Changes in lymphocytic cluster distribution during extracorporeal immunoadsorption. Artifical Organs 26(2):140\u2013144","journal-title":"Artifical Organs"},{"key":"3324_CR22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1055\/s-0028-1090231","volume":"36","author":"Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der A, Fischer M, Meyer C et al (2009) Plasmapherese in der Eskalationstherapie der Multiplen Sklerose: Verlaufsbeobachtung an 35\u00a0Patienten. Akt Neurol 36:105\u2013110","journal-title":"Akt Neurol"},{"key":"3324_CR23","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1586\/ern.09.81","volume":"9","author":"Schr\u00f6der","year":"2009","unstructured":"Schr\u00f6der A, Linker R, Gold R (2009) Plasmapheresis for neurological disorders. Expert Rev Neurother 9(9):1331\u20131339","journal-title":"Expert Rev Neurother"},{"key":"3324_CR24","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.clineuro.2004.12.019","volume":"107","author":"Seta","year":"2005","unstructured":"Seta T, Nagayama H, Katsura K et al (2005) Factors influencing outcome in Guillain-Barr\u00e9 Syndrome: comparison of plasma adsorption against other treatments. Clin Neurol Neurosurg 107:491\u2013496","journal-title":"Clin Neurol Neurosurg"},{"key":"3324_CR25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1046\/j.1537-2995.1989.29289146829.x","volume":"29","author":"Sutton","year":"1989","unstructured":"Sutton DM, Nair RC, Rock G (1989) Complications of plasma exchange. Transfusion 29(2):121\u2013127","journal-title":"Transfusion"},{"key":"3324_CR26","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1159\/000224630","volume":"28","author":"Trebst","year":"2009","unstructured":"Trebst C, Reising A, Kielstein J et al (2009) Plasma exchange therapy in steriod-unresponsive relapses in patients with multiple sclerosis. Blood Purif 28:108\u2013115","journal-title":"Blood Purif"},{"key":"3324_CR27","unstructured":"Wagner D, Kitze B, Klingel R et al (2009) Immunoadsorption in 8 multiple sclerosis patients with optic neuritis refractory to corticosteroids. Nieren-Hochdruckkrankh 38(9):457"},{"key":"3324_CR28","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1055\/s-0028-1100928","volume":"133","author":"Wagner","year":"2008","unstructured":"Wagner S, Janzen RW, Mohs C et al (2008) Long-term treatment of refractory myasthenia gravis with immunoadsorption. Dtsch Med Wochenschr 133:2377\u20132382","journal-title":"Dtsch Med Wochenschr"},{"key":"3324_CR29","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/1531-8249(199912)46:6<878::AID-ANA10>3.0.CO;2-Q","volume":"46","author":"Weinshenker","year":"1999","unstructured":"Weinshenker BG, O\u2018Brien PC, Petterson TM et al (1999) A randomised trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol 46:878\u2013886","journal-title":"Ann Neurol"}],"container-title":["Der Nervenarzt"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3324-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00115-011-3324-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00115-011-3324-5","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,11]],"date-time":"2019-06-11T16:21:27Z","timestamp":1560270087000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00115-011-3324-5"}},"subtitle":["Klinische Erfahrungen bei 14\u00a0Patienten"],"short-title":[],"issued":{"date-parts":[[2011,6,12]]},"references-count":29,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2011,12]]}},"alternative-id":["3324"],"URL":"https:\/\/doi.org\/10.1007\/s00115-011-3324-5","relation":{},"ISSN":["0028-2804","1433-0407"],"issn-type":[{"value":"0028-2804","type":"print"},{"value":"1433-0407","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,6,12]]}}}